UPDATE: Piper Sandler Starts aTyr Pharma (LIFE) at Overweight, Sees 86% Upside
Tweet Send to a Friend
(Updated - September 21, 2021 7:59 AM EDT)
Piper Sandler analyst Edward Tenthoff initiates coverage on aTyr Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Edward Tenthoff initiates coverage on aTyr Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
